Billy Evans on Elizabeth Holmes: Trial, Prison, Hemantis

A woman in a floppy hat and dark sunglasses, with a Band-Aid on her cheek from a husky scratch, strikes up a conversation at a Fleet Week party on a San Francisco rooftop. She asks about everything, the way a child asks about everything, and she watches the Blue Angels overhead with what her future husband later calls childlike wonder. He has no idea who she is. That is the opening scene Billy Evans gives for how he met Elizabeth Holmes, the founder convicted of defrauding investors in the blood-testing startup Theranos, and it is the frame for the whole conversation: a man asking a stadium of strangers to separate the person he knows from the story everyone else has already finished writing.

The timeline matters here, because it is the spine of Evans's case for sympathy. He and Holmes met on October 7, 2017 (05:14), after journalist John Carreyrou's investigative articles had already run but before Holmes was indicted. They spent six months as platonic dog-walking friends, Evans using his roommate's husky as a prop, before the relationship turned romantic (07:40). Three weeks later, she was indicted (08:40). "It's one hell of an experience to fall in love with somebody so quickly and then immediately come to terms with, like, I didn't even know what an indictment was," he says. What followed was not a glamorous countdown to trial but eight months living off-grid in an RV with their husky, Balto, parking in national forests for the maximum 14 days allowed, hiking by day and working by firelight, specifically to escape a press corps that photographed them at friends' birthday dinners and turned it into a story about a fraudster gallivanting around San Francisco (11:38).

The Case Against the Narrative

Evans's central argument is that the public settled on a verdict about Holmes's character before the jury settled on one about her conduct, and that the character verdict was built on language nobody would use for a man. "If you look back, like with as much clarity as you can muster, some of it's pretty crazy," he says. "That she would manipulate people with her big blue eyes, and that her deep voice would immediately have people give her a hundred million dollars. I mean, it's incredibly sexist" (13:44). He does not deny Theranos missed revenue targets; he argues the missed numbers came from Walgreens defaulting on a contractual rollout across roughly 800 stores after bad press broke, not from invented projections (15:56).

The trial itself is where Evans tries to do real work with numbers. The government charged 13 counts total. Theranos ran about 12.5 million blood tests on patients over an 18-month stretch, and prosecutors built four of those counts around four specific patients they said received knowingly false results (19:31, 19:52). Holmes was acquitted on all of them (20:27). Evans frames this as a statistics problem as much as a legal one: "Diagnostics is, like, an inherently inaccurate space. Ninety percent accuracy for some tests is good, and for other really inaccurate tests, seventy percent is really good," he says, arguing that four disputed results out of 12.5 million tests is not evidence of systemic fraud (21:00). Whatever the merits of that framing, the acquittal is a matter of record, and it is the part of the case least discussed in the popular retellings Evans is pushing back against.

What she was convicted of is a narrower, more technical thing: conspiracy to commit wire fraud against three investors, plus substantive fraud counts tied to them. That conspiracy charge did heavier lifting than its name suggests. Under federal sentencing rules, a conspiracy conviction let the judge widen the pool of people counted as victims, which is how media mogul Rupert Murdoch, who was never part of the original counts Holmes was convicted on, got added at sentencing (21:31, 21:41). Evans says that single mechanism is what moved her exposure from something like four and a half or five years up to 135 months, 11.25 years (37:52, 00:27). The $435 million in restitution she now owes is built from claims by ten investors, even though, Evans says, the government itself argued at a later hearing that none of those investors suffered actual financial hardship from the loss (37:00, 38:08).

The Arithmetic of Getting Out

The back half of the conversation turns into something closer to a tutorial on how a federal sentence actually gets served, and it is the most concrete, least contested material in the whole hour. Holmes is housed at Bryan Federal Prison Camp in College Station, Texas, alongside roughly 800 other women; she has been there more than 1,200 days, and on a typical weekend only about 30 of those 800 women get a visitor (28:05, 28:42). Evans situates his own circumstance inside a much larger one: 130 million Americans have a family member who has been or will be incarcerated, he says, a figure meant to puncture the uniqueness of his own grief (28:42).

"I recognize that I'm not unique in that. There's 130 million Americans who have a family member that will be incarcerated." — Billy Evans (28:42)

The mechanism that is actually shortening Holmes's sentence is the First Step Act, a 2018 federal law passed during President Trump's first term. Evans explains it as a kind of point system: an inmate can earn 16 days off her sentence for every 30 days spent in programming proven to reduce recidivism, which is the likelihood of returning to prison after release (36:36). Those earned days move a sentence through three stages, time inside the facility itself, time at a halfway house, and time on home confinement. By Evans's account, Holmes is now expected to reach a halfway house around the second quarter of next year. He also describes a detail that functions almost as a tax: 70 percent of any money sent to her prison commissary account is automatically deducted toward the restitution balance, which is why, he says, their last visit together consisted largely of buying trail mix from vending machines (36:56, 37:12).

The emotional centerpiece of the hour is the morning Holmes reported to prison. Evans describes driving her there, the ill-fitting New Balance sneakers a prison consultant had assured them were standard issue, and a final hug outside the facility. "I just hugged her and I said, 'I love you more than everything.' And she looked at me and she said, 'Now we are free,'" he says (31:08). It is a strange sentence to put in a prison parking lot, and Evans does not unpack it, but the context he has just spent half an hour building, years of being recognized in restaurants, photographed at private dinners, narrated by strangers, makes the line legible: incarceration, in his telling, ended a different kind of confinement.

A Documentary and a New Company

Two things exist now because of this period: a documentary called You Can See Everything, filmed over three years and timed to release only after Holmes's gag order and appeals process ended, and a startup called Hemantis that Evans is building without her. He is candid about why the press keeps calling it Theranos 2.0. "It's a lot easier to make it seem like Elizabeth Holmes is El Chapo running a diagnostics cartel from prison than it is to say Billy's building a nerdy company," he says (41:02). The actual company, by his description, uses Raman spectroscopy, a decades-old lab technique where laser light shone through a biological sample scatters and changes color in ways that reveal its chemical makeup. Existing Raman machines cost millions of dollars and take up entire rooms; Evans, who previously built lidar sensors for self-driving cars at a company called Luminar, says his contribution is shrinking and cheapening that sensor so it can feed large, messy data sets to artificial intelligence models looking for correlations human doctors were never built to see (39:57, 40:19).

What makes the interview worth sitting with is not whether it resolves the Theranos case, it explicitly does not try to, but how plainly it shows the gap between a legal record and a public verdict. The jury acquitted on every patient count and convicted on a narrower financial one. The sentence that followed was shaped less by the number of tests Theranos ran than by a conspiracy statute's reach into who counts as a victim. Evans is not asking anyone to forget the conviction. He is asking them to notice how much of the story that made the conviction feel inevitable was built on an interpretation of her voice, her eyes, her turtleneck, rather than on the counts a jury actually returned.